Sidley represented Omnicell in its definitive agreement with Pharmaceutical Strategies Group (PSG) to acquire its 340B Link business for US$225 million. Learn more here.
Sidley Represents Omnicell in Acquisition of Pharmaceutical Strategies Group’s Leading Software Business
Aug 19, 2020
Posted by Sidley Austin